Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
Loading
Debt-to-equity ratio
3Y CAGR
-6.1%/yr
Annual compound
Percentile
P60
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.02 | +16.8% |
| 2024 | 0.02 | -46.2% |
| 2023 | 0.04 | +31.7% |
| 2022 | 0.03 | +112.3% |
| 2021 | -0.24 | -3328.8% |
| 2020 | -0.01 | - |